The opioid use disorder (OUD) epidemic extends beyond the boundaries of traditional state health systems, requiring evidence-based treatment and coordination between state agencies and leaders. To optimize all potential avenues to treatment and reduce overdoses, the National Academy for State Health Policy (NASHP) is working with states to develop a “no-wrong-door” approach to treatment that prioritizes cross-systems policies. NASHP is providing tools and resources with support from the Foundation for Opioid Response Efforts (FORE) and its steering committee. Read our newest blog, State Harm Reduction Services Get Creative in the COVID-19 Era.
In 2019, more than 500,000 individuals experienced homelessness and nearly 20 million renters spent 30 percent or more of their income on housing. These numbers are increasing as the COVID-19 pandemic exacerbates housing insecurity for people of color and low-wage workers. To improve housing stability – a critical social determinant of health (SDOH) – states […]
As state policymakers confront the substance use disorder (SUD) epidemic, they require a wide range of data – often found in disparate systems – to understand its impact and craft more effective treatment programs and interventions. This report explores best practices and sources for data gathering and describes how states can help communities access and […]
Update: On Jan. 27, 2021, the Office of National Drug Control Policy (ONDCP) notified stakeholders that the earlier announcement from the Department of Health and Human Services (HHS) that physicians will no longer have to obtain a federal waiver to prescribe the opioid use disorder treatment buprenorphine to patients – as described in this blog – will not […]
As drug overdose deaths accelerate during the COVID-19 pandemic, states are working to ensure that a continuum of services, including access to harm reduction programs, remain available to people with substance use disorder (SUD). The National Academy for State Health Policy (NASHP) recently spoke to Louisiana’s Viral Hepatitis Coordinator Emilia Myers and STD/HIV/Hepatitis Program Deputy […]
Despite COVID-19 workarounds, such as telehealth and virtual recovery programs enabled by flexible federal guidelines, more than 40 states have reported increases in drug overdoses during the pandemic, underscoring the importance of keeping state harm reduction programs as accessible as possible. As COVID-19 upends the nation’s health care systems, treatment for substance use disorder (SUD) […]
In response to COVID-19, states have made swift and unprecedented changes to enable the use of telehealth to meet the public’s need to safely access care remotely. Now, policymakers face the challenge of analyzing whether to sustain these changes as they weigh cost, privacy, and security considerations and effectiveness of remote care delivery. As officials […]
As drug overdose fatalities continue to rise and incarceration rates remain high nationwide despite recent declines, states are increasingly developing opportunities for incarcerated individuals to access evidence-based opioid use disorder (OUD) treatment in state prison facilities. While the forced abstinence during incarceration can temporarily pause substance use itself, providing comprehensive treatment that includes medications for […]